Daejeon, South Korea

In Suk Park

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sk Biopharmaceuticals Co., Ltd.. Active years: 2014-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: In Suk Park. Retrieved from https://idiyas.com/inventor/in-suk-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: In Suk Park: Innovator in Neurodegeneration Research

Introduction

In Suk Park is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of neurodegeneration. With a total of 2 patents, his work focuses on innovative solutions for treating neuronal apoptosis.

Latest Patents

In Suk Park's latest patents include a pharmaceutical composition designed for inhibiting apoptosis of neurons or neurodegeneration. This composition effectively prevents or treats diseases related to neuronal apoptosis, showcasing his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Park is currently associated with SK Biopharmaceuticals Co., Ltd., where he continues to develop groundbreaking pharmaceutical solutions. His expertise in neurodegeneration has positioned him as a key player in the industry, contributing to the advancement of therapeutic options for patients suffering from related conditions.

Collaborations

Some of his notable coworkers include Mi Jung Lim and Cheol Hyoung Park, who collaborate with him in various research initiatives. Their combined efforts enhance the innovative capacity of their projects and contribute to the overall success of their endeavors.

Conclusion

In Suk Park's work exemplifies the spirit of innovation in the pharmaceutical industry, particularly in addressing neurodegenerative diseases. His contributions are vital for the ongoing development of effective treatments, and his patents reflect a commitment to improving health outcomes for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…